Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
prostate | 98% | 1618.27 | 240 / 245 | 99% | 18.32 | 497 / 502 |
liver | 100% | 2333.18 | 225 / 226 | 85% | 6.74 | 347 / 406 |
intestine | 99% | 5417.47 | 959 / 966 | 85% | 5.76 | 449 / 527 |
lung | 100% | 2427.47 | 577 / 578 | 75% | 4.19 | 868 / 1155 |
pancreas | 98% | 1186.46 | 323 / 328 | 67% | 4.98 | 119 / 178 |
bladder | 95% | 2628.14 | 20 / 21 | 66% | 3.85 | 332 / 504 |
esophagus | 72% | 913.04 | 1044 / 1445 | 77% | 4.70 | 141 / 183 |
stomach | 65% | 594.04 | 234 / 359 | 77% | 5.19 | 220 / 286 |
brain | 60% | 809.02 | 1595 / 2642 | 72% | 2.84 | 506 / 705 |
breast | 76% | 3558.49 | 348 / 459 | 35% | 1.67 | 392 / 1118 |
spleen | 100% | 1619.86 | 241 / 241 | 0% | 0 | 0 / 0 |
adipose | 99% | 5401.87 | 1190 / 1204 | 0% | 0 | 0 / 0 |
skin | 5% | 39.61 | 97 / 1809 | 80% | 12.29 | 378 / 472 |
peripheral blood | 85% | 1332.16 | 788 / 929 | 0% | 0 | 0 / 0 |
heart | 79% | 712.11 | 680 / 861 | 0% | 0 | 0 / 0 |
kidney | 34% | 233.37 | 30 / 89 | 26% | 1.55 | 232 / 901 |
lymph node | 0% | 0 | 0 / 0 | 59% | 4.10 | 17 / 29 |
tonsil | 0% | 0 | 0 / 0 | 56% | 2.27 | 25 / 45 |
adrenal gland | 4% | 25.74 | 10 / 258 | 45% | 2.71 | 103 / 230 |
blood vessel | 48% | 732.07 | 635 / 1335 | 0% | 0 | 0 / 0 |
uterus | 7% | 55.07 | 12 / 170 | 29% | 1.63 | 135 / 459 |
thymus | 17% | 136.30 | 113 / 653 | 8% | 0.30 | 46 / 605 |
eye | 0% | 0 | 0 / 0 | 21% | 1.24 | 17 / 80 |
ovary | 3% | 14.86 | 5 / 180 | 4% | 0.18 | 19 / 430 |
muscle | 3% | 20.00 | 22 / 803 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0001525 | Biological process | angiogenesis |
GO_0032869 | Biological process | cellular response to insulin stimulus |
GO_0007162 | Biological process | negative regulation of cell adhesion |
GO_0019933 | Biological process | cAMP-mediated signaling |
GO_0033629 | Biological process | negative regulation of cell adhesion mediated by integrin |
GO_0016525 | Biological process | negative regulation of angiogenesis |
GO_0007186 | Biological process | G protein-coupled receptor signaling pathway |
GO_0050995 | Biological process | negative regulation of lipid catabolic process |
GO_0106072 | Biological process | negative regulation of adenylate cyclase-activating G protein-coupled receptor signaling pathway |
GO_0032045 | Cellular component | guanyl-nucleotide exchange factor complex |
GO_0016020 | Cellular component | membrane |
GO_0005794 | Cellular component | Golgi apparatus |
GO_0005783 | Cellular component | endoplasmic reticulum |
GO_0005829 | Cellular component | cytosol |
GO_0004114 | Molecular function | 3',5'-cyclic-nucleotide phosphodiesterase activity |
GO_0004119 | Molecular function | cGMP-inhibited cyclic-nucleotide phosphodiesterase activity |
GO_0047555 | Molecular function | 3',5'-cyclic-GMP phosphodiesterase activity |
GO_0046872 | Molecular function | metal ion binding |
GO_0043422 | Molecular function | protein kinase B binding |
GO_0004115 | Molecular function | 3',5'-cyclic-AMP phosphodiesterase activity |
GO_0005515 | Molecular function | protein binding |
Gene name | PDE3B |
Protein name | cGMP-inhibited 3',5'-cyclic phosphodiesterase 3B (EC 3.1.4.17) (CGIPDE1) (CGIP1) (Cyclic GMP-inhibited phosphodiesterase B) (CGI-PDE B) Phosphodiesterase (EC 3.1.4.-) |
Synonyms | |
Description | FUNCTION: Cyclic nucleotide phosphodiesterase with a dual-specificity for the second messengers cAMP and cGMP, which are key regulators of many important physiological process . Regulates angiogenesis by inhibiting the cAMP-dependent guanine nucleotide exchange factor RAPGEF3 and downstream phosphatidylinositol 3-kinase gamma-mediated signaling . Controls cardiac contractility by reducing cAMP concentration in cardiocytes (By similarity). . |
Accessions | A7E2E5 Q13370 ENST00000282096.9 [Q13370-1] ENST00000455098.2 [Q13370-2] |